Search

everythinglearnresearchcommunity

for

Search:↓

In a Tuscan pediatric clinic, 7.19% of children had hair or scalp disorders, with nonscarring alopecia being the most common.

Stress may trigger hair loss by affecting immune protection in hair follicles.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Some drugs used to treat immune conditions may cause different types of hair loss.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Anti-TNF therapy can cause hair loss and skin issues.

Immune cells affect hair growth and could lead to new hair loss treatments.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Fetal skin has unique immune cells different from adult skin.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Leflunomide is more likely to help treat alopecia areata than cause it.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.